BNET Industries

Market Cap:$184.5M
Last Fiscal Year Sales:$3.6B
  • Public
  • DK
Dow Jones Description

Mfr. of Food Ingredients, Sugar & Sweetening Products

Executive Vice President & CEO, Danisco Sugar
Mogens Granborg
Number of Employees 8,936
Contact Information

Langebrogade 1

Copenhagen DK 1001

www.danisco.com

(45) 932662000

NAICS Code Dried and Dehydrated Food Manufacturing: 311423

News & Analysis

danisco a/s and genencor international inc. - All News and Analysis

Decision Makers

Name (plus bio) Position
Mogens Granborg Executive Vice President & CEO, Danisco Sugar
Fabienne Saadane-Oaks President, Bio Actives
Soren Bjerre Nielsen CFO & Executive Vice President
Torben Svejgaard COO, Products Divisions
Leif Kjaergaard Executive Vice President, Res & Development
Mats Liljestam Executive Vice President, Sales & Marketing
Robert Mayer Executive Vice President, Ingredients Sector
Stephane Constant Executive Vice President, Sweeteners Division
Klaus Friis-Hansen Vice President, HR
Michael Von Bulow Vice President, Communications
Poul Jorgen Jensen Vice President, Merger & Acq
Carl Johan Corneliussen Manager, Media Relations
Natalie E. Weber Manager, Media Relations
Alf Duch
Angelica Horst
Danisco Cotia
Danisco Sugar hf
Danisco Thailand
Erik Harlem
Flemming Kristensen
Fritz Hansen
Gregorio Ruiz
J L Tiedemanns Tobaksfabrik
Juha Kurkinen General Counsel
Lis Glibstrup
Mario Ruiz Hermesdorf
Paul Vet
Peter HOjland
SOren Bjerre
Tom Knutzen
Wang Linfeng
Wilhelm Fenger

Board of Directors

Name (plus bio) Position
Jorgen Tandrup Deputy Chairman
Anders Knutsen Board of Directors
Bo Berggren Board of Directors
Borge A. Pedersen Board of Directors
Erik B. Rasmussen Board of Directors
Finn Larsen Board of Directors
Hakan Bjorklund Board of Directors
Heimo Karinen Board of Directors
Jon Krabbe Board of Directors
Matti Vuoria Board of Directors
Peter Hoejland Board of Directors
Sten Scheibye Board of Directors

Organization Position Status
Danisco A/S Executive Vice President & CEO, Danisco Sugar Current

Organization Position Status
Danisco A/S President, Bio Actives Current

Organization Position Status
Danisco A/S CFO & Executive Vice President Current

Organization Position Status
Danisco A/S COO, Products Divisions Current

Organization Position Status
Danisco A/S Executive Vice President, Res & Development Current

Organization Position Status
Danisco A/S Executive Vice President, Sales & Marketing Current

Robert Mayer is Chairman and Chief Executive Officer of Genencor International. Previously, as Executive Vice President of Danisco, he served on Genencor's Board of Directors. He has held numerous management positions at Danisco since 1981. Bob holds a Masters in Engineering and a Ph.D. in Chemical Engineering.

Organization Position Status
Genencor Chairman and Chief Executive Officer Current
Danisco A/S Executive Vice President, Ingredients Sector Current
Martek Biosciences Corporation Board of Directors Current
Genencor International, Inc. Chief Executive Officer Former
Genencor Executive Vice President of Danisco Former
Genencor International, Inc. Chairman of the Board Former
Genencor Board of Directors Former

Organization Position Status
Danisco A/S Executive Vice President, Sweeteners Division Current

Organization Position Status
Danisco A/S Vice President, HR Current

Organization Position Status
Danisco A/S Vice President, Communications Current

Organization Position Status
Danisco A/S Vice President, Merger & Acq Current

Organization Position Status
Danisco A/S Manager, Media Relations Current

Organization Position Status
Danisco A/S Manager, Media Relations Current

Organization Position Status
Danisco A/S Current
Danske Bank A/S Chairman Former

Organization Position Status
Danisco A/S Current

Organization Position Status
Danisco A/S Current

Organization Position Status
Danisco A/S Current

Organization Position Status
Danisco A/S Current

Organization Position Status
Danisco A/S Current

Organization Position Status
Danisco A/S Current

Organization Position Status
Danisco A/S Current
Copenhagen Business School Chairman Former

Organization Position Status
Danisco A/S Current

Organization Position Status
Danisco A/S Current

Organization Position Status
Danisco A/S General Counsel Current

Organization Position Status
Danisco A/S Current

Organization Position Status
Danisco A/S Current

Organization Position Status
Danisco A/S Current

Organization Position Status
Danisco A/S Current

Organization Position Status
Danisco A/S Current
Carlsberg A/S Director Former

Organization Position Status
Danisco A/S Current

Organization Position Status
Danisco A/S Current

Organization Position Status
Danisco A/S Current

Organization Position Status
Danisco A/S Deputy Chairman Current
Danisco A/S Board of Directors Current

Organization Position Status
Danisco A/S Board of Directors Current
Danisco A/S Chairman Former

Organization Position Status
Danisco A/S Board of Directors Current

Organization Position Status
Danisco A/S Board of Directors Current

Organization Position Status
Danisco A/S Board of Directors Current

Organization Position Status
Danisco A/S Board of Directors Current

Organization Position Status
Xefo Chief Executive Officer Current
Nycomed, Inc. Chief Executive Officer Current
Danisco A/S Board of Directors Current
Coloplast Ltd. Board of Directors Current
Danisco A/S CEO Former

Organization Position Status
Danisco A/S Board of Directors Current

Organization Position Status
Danisco A/S Board of Directors Current

Organization Position Status
Danisco A/S Board of Directors Current
Sampo plc Board of Directors Current

Organization Position Status
Danisco A/S Board of Directors Current

Organization Position Status
Danisco A/S Board of Directors Current

Executive News

  • Forest Laboratories, Inc. (FRX) (JOBS) to Sell Nycomed's Lung Drug Daxas in U.S.; Forest to Pay $100 Million Upfront, Up to $500 Million More Later

    BioSpace - 8/11/09 - View Story

  • Forest Laboratories, Inc. (FRX) to Sell Nycomed's Lung Drug Daxas in U.S.; Forest to Pay $100 Million Upfront, Up to $500 Million More Later

    BioSpace - 8/10/09 - View Story

  • Nycomed and Forest Laboratories to Collaborate on US Commercialisation of Daxas(R) in COPD

    PR Newswire via Yahoo! - 8/10/09 - View Story

  • Nycomed and Forest Laboratories to Collaborate on Daxas(R) (roflumilast) for COPD

    RBC Dain Raushcer - 8/10/09 - View Story

advertisement
DCO $17.66 -0.63 (-3.44% )
Volume 56,996
Shares Outstanding 10.4M
Market Cap 184.5M
Year High 21.44
Year Low 10.93
Earnings Per Share 0.88
P/E Ratio 20.0682
Dividend 0.30
Yield 1.6988
advertisement